Results 261 to 270 of about 583,184 (351)

Antioxidant-Effective Quercetin Through Modulation of Brain Interleukin-13 Mitigates Autistic-Like Behaviors in the Propionic Acid-Induced Autism Model in Rats. [PDF]

J Neuroimmune Pharmacol
Kılıç KD, Garipoğlu G, Çakar B, Uyanıkgil Y, Erbaş O.   +4 more
europepmc   +1 more source

Single‐Cell Dissection of Tumor‐Infiltrating Lymphocytes Reveals Cellular Architecture Predictive of Therapeutic Efficacy in Acral Melanoma

Advanced Science, EarlyView.
Autologous tumor‐infiltrating lymphocyte (TIL) therapy shows promising efficacy in acral melanoma, yet determinants of durable response remain unclear. By integrating single‐cell transcriptomics and TCR sequencing, this study reveals that TIL products enriched for T follicular helper and intermediate exhausted T cells establish persistent clonal ...
Chao Zhang, Wanyi Xiao, Hongru Shen, Fenge Li, Ting Li, Weihong Zhang, Haotian Liu, Ziwei Gao, Hongyu Wang, Xiubao Ren, Kexin Chen, Xiangchun Li, Jilong Yang   +12 more
wiley   +1 more source

New Role for Interleukin‐13 Receptor α1 in Myocardial Homeostasis and Heart Failure

, 2017
Uri Amit, David Kain, Allon Wagner, Avinash Sahu, Yael Nevo‐Caspi, Nir Gonen, Natali Molotski, Tal Konfino, Natalie Landa, Nili Naftali‐Shani, Galia Blum, Emmanuelle Merquiol, Danielle Karo‐Atar, Yariv Kanfi, Gidi Paret, Ariel Munitz, Haim Cohen, Eytan Ruppin, Sridhar Hannenhalli, Jonathan Leor   +19 more
openalex   +1 more source

Expanding the potential of monoclonal antibodies against interleukin-4 and interleukin-13 in genodermatoses: A case series on the efficacy and safety of dupilumab in epidermolysis bullosa and ichthyosis. [PDF]

JAAD Case Rep
Caroppo F, Mazzetto R, Milan E, Cassalia F, Belloni Fortina A.   +4 more
europepmc   +1 more source

First Generation Proteolysis Targeting Chimeras (PROTACs) for the Treatment of Progeria

Advanced Science, EarlyView.
We report the first PROTACs designed to degrade progerin, introducing a novel therapeutic approach for progeria. The best compound, UCM‐18142, significantly reduces progerin levels and improves key disease phenotypes in patient‐derived cells and in the LmnaG609G/G609G mouse model, paving the way for new treatment strategies targeting the root cause of ...
Jon Macicior‐Michelena, Marcelino Telechea, Daniel Fernández, Alba García‐Martín, Ángeles Canales, Silvia Ortega‐Gutiérrez   +5 more
wiley   +1 more source

High Interleukin-13 level is associated with disease stability in interstitial Lung disease. [PDF]

Heliyon
Joerns EK, Karp D, Zhang S, Sparks JA, Adams TN, Makris UE, Newton CA.   +6 more
europepmc   +1 more source

Preterm ovine respiratory epithelial cell responses to mechanical ventilation, lipopolysaccharide, and interleukin-13.

Am J Physiol Lung Cell Mol Physiol, 2023
Abugisisa L, Royse EX, Kemp MW, Jobe AH, Hillman NH.   +4 more
europepmc   +1 more source

Enhancing CAR‐T Cell Efficacy in Solid Tumors by Inhibiting CCL5/VEGF‐Mediated Angiogenesis

Advanced Science, EarlyView.
This study reveals that CAR‐T cells in solid tumors produce CCL5, which paradoxically induces VEGF and angiogenesis to promote tumor growth. Blocking CCL5/VEGF signaling—through gene knockout, or the CCR5 inhibitor maraviroc—significantly enhances the antitumor efficacy of CAR‑T therapy (the diagram was created in Biorender).
Shishuo Sun, Qihong Li, Bixi Wang, Gang Wang, Ying Xue, Yibing Liang, Chenhe Hu, Zhenyu Wang, Xiaoge Gao, Haiheng Xu, Jun Song, Hailong Li, Liantao Li, Xiaoxiao Liu, Patrick Ming‐Kuen Tang, Qing Zhang   +15 more
wiley   +1 more source

The receptors for Interleukin-4- and Interleukin-13: in vivo and in vitro studies characterizing their distribution, regulation, and signal transduction in human target cells

, 1996
Serena M. Lugli
openalex   +1 more source

Mineral coated microparticles delivering Interleukin-4, Interleukin-10, and Interleukin-13 reduce inflammation and improve function after spinal cord injury in a rat. [PDF]

Exp Neurol
Hellenbrand DJ, Lee JS, Mickelson EJ, Baer MC, Ott EL, Martinson NR, Ceelen MR, Hilger KH, Nielsen BE, Jacobs AN, Mishra RR, Hurley SA, Murphy WL, Hanna AS.   +13 more
europepmc   +1 more source